Mapping Spatial Genetic Landscapes in Tissue Sections through Microscale Integration of Sampling Methodology into Genomic Workflows
Source abstract
Abstract
Abstract In cancer research, genomic profiles are often extracted from homogenized macrodissections of tissues, with the histological context lost and a large fraction of material underutilized. Pertinently, the spatial genomic landscape provides critical complementary information in deciphering disease heterogeneity and progression. Microscale sampling methods such as microdissection to obtain such information are often destructive to a sizeable fraction of the biopsy sample, thus showing limited multiplexability and adaptability to different assays. A modular microfluidic technology is here implemented to recover cells at the microscale from tumor tissue sections, with minimal disruption of unsampled areas and tailored to interface with genome profiling workflows, which is directed here toward evaluating intratumoral genomic heterogeneity. The integrated workflow—GeneScape—is used to evaluate heterogeneity in a metastatic mammary carcinoma, showing distinct single nucleotide variants and copy number variations in different tumor tissue regions, suggesting the polyclonal origin of the metastasis as well as development driven by multiple location‐specific drivers.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Single-cell and spatial transcriptomics · Cancer Genomics and Diagnostics · Gene expression and cancer classification
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
IBM Research Europe Säumerstrasse 4 Rüschlikon CH‐8803 Switzerland
Functional Genomics Center Zurich Winterthurerstr. 190 Zurich CH‐8057 Switzerland
Center for Genomics and Transcriptomics Paul‐Ehrlich‐Str. 23 72076 Tübingen Germany
Department of Pathology and Molecular Pathology University Hospital Zurich Schmelzbergstr. 12 Zurich CH‐8091 Switzerland
Funding
Functional Genomics Center Zurich · H2020 European Research Council
References (65)
Show source-provided references
1. Calderwood S. K. · Discov. Med. · 2013 · 15 · 188
2. 10.1172/JCI5708810.1172/JCI57088 ↗
3. 10.1101/gr.099622.10910.1101/gr.099622.109 ↗
4. 10.1016/j.molcel.2019.05.00310.1016/j.molcel.2019.05.003 ↗
5. 10.1038/s41556-018-0236-710.1038/s41556-018-0236-7 ↗
6. 10.1101/gr.191098.11510.1101/gr.191098.115 ↗
7. 10.1586/14737159.2015.106918210.1586/14737159.2015.1069182 ↗
8. 10.1038/nmeth.256310.1038/nmeth.2563 ↗
9. 10.1126/science.aaw121910.1126/science.aaw1219 ↗
10. 10.1038/s41592-019-0548-y10.1038/s41592-019-0548-y ↗
11. 10.1038/nmeth72310.1038/nmeth723 ↗
12. 10.1038/nmeth.144810.1038/nmeth.1448 ↗
13. 10.1126/science.125021210.1126/science.1250212 ↗
14. 10.1126/science.aaf240310.1126/science.aaf2403 ↗
15. 10.20892/j.issn.2095-3941.2016.000410.20892/j.issn.2095-3941.2016.0004 ↗
16. 10.1038/ncomms1213910.1038/ncomms12139 ↗
17. 10.1038/nprot.2017.00310.1038/nprot.2017.003 ↗
18. 10.1186/s13059-018-1543-910.1186/s13059-018-1543-9 ↗
19. 10.1186/1472-6890-13-2910.1186/1472-6890-13-29 ↗
20. 10.1021/la200363910.1021/la2003639 ↗
21. 10.1038/s41551-019-0386-310.1038/s41551-019-0386-3 ↗
22. 10.1093/nar/gkz115110.1093/nar/gkz1151 ↗
23. 10.1038/srep2957910.1038/srep29579 ↗
24. 10.1002/anie.20190715010.1002/anie.201907150 ↗
25. 10.1038/ncomms442110.1038/ncomms4421 ↗
26. 10.1158/1535-7163.MCT-15-064310.1158/1535-7163.MCT-15-0643 ↗
27. 10.1371/journal.pone.019643410.1371/journal.pone.0196434 ↗
28. 10.18632/oncotarget.1722510.18632/oncotarget.17225 ↗
29. Smith N. · bioRxiv · 2018 · 21 · 264267
30. 10.1038/s41586-020-1969-610.1038/s41586-020-1969-6 ↗
31. 10.1172/jci.insight.12790110.1172/jci.insight.127901 ↗
32. 10.1016/j.semcdb.2016.08.02510.1016/j.semcdb.2016.08.025 ↗
33. 10.1093/nar/gky96210.1093/nar/gky962 ↗
34. 10.1186/s12885-018-4388-410.1186/s12885-018-4388-4 ↗
35. 10.1038/ng.364110.1038/ng.3641 ↗
36. 10.1038/nrc397110.1038/nrc3971 ↗
37. 10.1016/j.ccell.2014.12.00110.1016/j.ccell.2014.12.001 ↗
38. 10.1016/S1470-2045(11)70335-710.1016/S1470-2045(11)70335-7 ↗
39. 10.1038/s41588-020-0628-z10.1038/s41588-020-0628-z ↗
40. 10.1073/pnas.152567711310.1073/pnas.1525677113 ↗
41. 10.1136/esmoopen-2016-00009410.1136/esmoopen-2016-000094 ↗
42. 10.3389/fmed.2018.0008510.3389/fmed.2018.00085 ↗
43. 10.1373/clinchem.2012.19471210.1373/clinchem.2012.194712 ↗
44. 10.1158/2159-8290.CD-13-104210.1158/2159-8290.CD-13-1042 ↗
45. 10.1056/NEJMoa111320510.1056/NEJMoa1113205 ↗
46. Albiges L. · Cancer Res. · 2012 · 72 · 174610.1158/1538-7445.AM2012-1746 ↗
47. 10.1371/journal.pbio.100190610.1371/journal.pbio.1001906 ↗
48. 10.1056/NEJMoa161628810.1056/NEJMoa1616288 ↗
49. 10.1016/S0169-5002(18)30217-410.1016/S0169-5002(18)30217-4 ↗
50. B.Rybinski K.Yun Oncotarget2016 7 72322.10.18632/oncotarget.11875 ↗
51. 10.12788/jcso.040710.12788/jcso.0407 ↗
52. 10.1078/0344-0338-0050110.1078/0344-0338-00501 ↗
53. Kashyap A. · J. Vis. Exp. · 2016 · 2016 · e54447
54. 10.1186/s12859-016-1104-810.1186/s12859-016-1104-8 ↗
55. 10.1101/gr.107524.11010.1101/gr.107524.110 ↗
56. Andrews S. · Babraham Bioinf. · 2010
57. 10.12688/f1000research.15931.210.12688/f1000research.15931.2 ↗
58. 10.1038/nmeth.192310.1038/nmeth.1923 ↗
59. Okonechnikov K. · Bioinformatics · 2016 · 32 · 29210.1093/bioinformatics/btv566 ↗
60. 10.1101/gr.114876.11010.1101/gr.114876.110 ↗
61. 10.1093/bioinformatics/btw04110.1093/bioinformatics/btw041 ↗
62. 10.1093/nar/27.1.2910.1093/nar/27.1.29 ↗
63. 10.1093/nar/gks114710.1093/nar/gks1147 ↗
64. 10.1093/nar/gki47510.1093/nar/gki475 ↗
65. 10.1093/nar/gkt43910.1093/nar/gkt439 ↗